IBD barriers across the continents: a continent-specific analysis: Latin America.
Natália Souza Freitas QueirozCamilla de Almeida MartinsAbel Botelho QuaresmaPablo A Olivera SendraKenneth Ernest-SuarezPaulo Gustavo KotzePublished in: Therapeutic advances in gastroenterology (2023)
Latin America (LATAM) is a large region comprising 47 countries and territories. Each one carries a different cultural and historical background, diverse political systems, and a particular approach to healthcare management. There is a lack of high-quality data on the epidemiology of inflammatory bowel diseases (IBD) in this region, including broad and detailed information about the penetration of biological and advanced therapies as treatment strategies. From an IBD perspective, patients experience, in general, fragmentations and inequities in the healthcare systems, with different and usually delayed access to qualified health services. This review explores the barriers to accessing IBD care throughout LATAM. The authors compiled data from multiple sources, such as studies focusing on epidemiology, biological penetration, and surgical rates. In addition, overall access to IBD treatments was assessed through a questionnaire distributed to physicians in LATAM via email and direct messaging to capture local perspectives.
Keyphrases
- healthcare
- ulcerative colitis
- electronic health record
- newly diagnosed
- ejection fraction
- big data
- primary care
- quality improvement
- health information
- patient reported
- machine learning
- pain management
- cross sectional
- drinking water
- health insurance
- affordable care act
- chronic pain
- psychometric properties
- data analysis